• Behavioral treatment for deficits of fac

    From ScienceDaily@1:317/3 to All on Tue Apr 12 22:30:44 2022
    Behavioral treatment for deficits of facial affect recognition in
    multiple sclerosis

    Date:
    April 12, 2022
    Source:
    Kessler Foundation
    Summary:
    A recent study has demonstrated efficacy for the behavioral
    intervention, EMOPRINT, for treating deficits of facial recognition
    in individuals with multiple sclerosis (MS). The study provides
    Class I evidence supporting the efficacy of an intervention to
    treat these deficits in MS.



    FULL STORY ==========================================================================
    A recent study by Kessler Foundation researchers demonstrated efficacy for
    the behavioral intervention, EMOPRINT, for treating deficits of facial recognition in individuals with multiple sclerosis (MS). The article, "Emotional processing intervention (EMOPRINT): A blinded randomized
    control trial to treat facial affect recognition deficits in multiple sclerosis," was epublished on January 19, 2022, by Multiple Sclerosis
    and Related Disorders. The study is the first to provide Class I evidence supporting the efficacy of an intervention to treat these deficits in MS.


    ==========================================================================
    The authors are Helen M. Genova, PhD, Katie Lancaster, PhD, Zuzanna
    Myszko, Jimmy Morecraft, Jacqueline Leddy, Angela Smith, MA, Nancy Chiaravalloti, PhD, and Jean Lengenfelder, PhD, of Kessler Foundation.

    Researchers compared 21 individuals with MS with 15 placebo controls in
    this double-blinded, placebo-controlled, randomized clinical trial of
    EMOPRINT, a five-week, 12-session behavioral intervention for teaching
    facial recognition of the six universal emotions -- happiness, sadness,
    fear, surprise, anger, and disgust. Participants underwent baseline and follow-up neuropsychological assessments of facial affect recognition,
    as well as assessments of quality of life and emotional functioning. At
    follow up, facial affect recognition skills significantly improved in
    the MS group compared with the placebo group.

    The efficacy of EMOPRINT has important implications for individuals
    with MS, as well as for other populations that experience deficits
    of facial recognition, including autism, traumatic brain injury, and schizophrenia. Deficits in facial recognition, which are known to hinder
    social functioning, are often associated with mood disorders and reduced quality of life, according to lead author Dr.

    Genova, the Foundation's associate director of the Center for Autism
    Research and an expert in the study of social cognition.

    "Improving facial recognition may improve interpersonal relationships and
    lead to better outcomes at home and in the workplace," she added. "The
    success of EMOPRINT in this MS study is an important first step toward
    the larger-scale, longer-term studies of social cognition we need to
    study these potential effects." Funding: National Multiple Sclerosis
    Society (RG-1507-05353)

    ========================================================================== Story Source: Materials provided by Kessler_Foundation. Note: Content
    may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Helen M. Genova, Katie Lancaster, Zuzanna Myszko, Jimmy Morecraft,
    Jacqueline Leddy, Angela Smith, Nancy Chiaravalloti, Jean
    Lengenfelder.

    Emotional processing intervention (EMOPRINT): A blinded randomized
    control trial to treat facial affect recognition deficits in
    multiple sclerosis. Multiple Sclerosis and Related Disorders,
    2022; 59: 103536 DOI: 10.1016/j.msard.2022.103536 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2022/04/220412141049.htm

    --- up 6 weeks, 1 day, 10 hours, 51 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)